Axonal Guillain-Barré syndrome: concepts and controversies

@article{Kuwabara2013AxonalGS,
  title={Axonal Guillain-Barr{\'e} syndrome: concepts and controversies},
  author={Satoshi Kuwabara and Nobuhiro Yuki},
  journal={The Lancet Neurology},
  year={2013},
  volume={12},
  pages={1180-1188}
}
Acute motor axonal neuropathy (AMAN) is a pure motor axonal subtype of Guillain-Barré syndrome (GBS) that was identified in the late 1990s. In Asia and Central and South America, it is the major subtype of GBS, seen in 30-65% of patients. AMAN progresses more rapidly and has an earlier peak than demyelinating GBS; tendon reflexes are relatively preserved or even exaggerated, and autonomic dysfunction is rare. One of the main causes is molecular mimicry of human gangliosides by Campylobacter… 
Axonal degeneration in Guillain–Barré syndrome: a reappraisal
TLDR
A novel pathophysiological mechanism for nerve trunk pain in GBS, including pure motor forms, is provided and the potential therapeutic role of intravenous boluses of methylprednisolone for early severe GBS and intractable pain is argued.
Axonal pathology in early stages of Guillain-Barré syndrome.
TLDR
Inflammatory oedema of the proximal nerve trunks can be observed in early stages of GBS, and it may cause nerve conduction failure and active axonal degeneration.
Immunotherapy of Guillain-Barré syndrome
TLDR
Good circumstantial evidence exists for a pathogenic role for molecular mimicry in GBS pathogenesis, especially with its axonal forms, providing insights that could guide future immunotherapy, and the potential of leukocyte trafficking inhibitors as novel disease-specific immunotherapeutic drugs is highlighted.
Proximal nerve lesions in early Guillain–Barré syndrome: implications for pathogenesis and disease classification
TLDR
The aim of this paper was to analyze the nosology of early GBS reviewing electrophysiological, autopsy and imaging studies, both in acute inflammatory demyelinating polyneuropathy (AIDP) and acute motor/motor-sensory axonal neuropathy (AMAN/AMSAN).
CSF Findings in Guillain-Barré Syndrome: Demyelinating and Axonal Acute Inflammatory Polyneuropathies
TLDR
Although most of these studies indicate alteration of the CSF and support the immunopathogenesis of GBS, albuminocytological dissociation described 100 years ago remains the only consistent CSF biomarker supporting the diagnosis of G BS after the second week of disease onset.
Axonal variants of Guillain–Barré syndrome: an update
TLDR
New developed technologies, including metabolite analysis, peripheral nerve ultrasound, and feature selection via artificial intelligence are facilitating more accurate diagnosis of axonal GBS, Nevertheless, some key issues, such as genetic susceptibilities, remain unanswered and moreover, current therapies bear limitations.
Forma axonal del síndrome de Guillain-Barré . Axonal form of Guillain-Barré síndrome Alumna
Fifty-two patients with Guillain-Barré syndrome (GBS) were retrospectively selected from a defined area (Cantabria) in Nothern Spain, from January 2009 to December 2016. According to
Guillain‐Barré syndrome: Novel treatment by complement inhibition
TLDR
In a murine model with anti‐ganglioside antibody–mediated neuropathy, eculizumab can avert respiratory failure and motor neuropathy and a randomized controlled phase II trial showed that eculIZumab might be effective also for GBS patients.
Acute Motor Sensory Axonal Neuropathy: A Variant of Guillain–Barré Syndrome—A Rare Case Report
TLDR
A 60-year-old male presented to the emergency department having complaints of weakness, numbness, and tingling sensation in feet for the last fortnight, which ascended gradually towards the calves, which was indicative of AMSAN variant of Guillain–Barré syndrome.
Acute Motor Axonal Neuropathy in Association with Hepatitis E
TLDR
A young woman had unexplained muscle weakness at admission and has been diagnosed with acute hepatitis E infection, and a rigorous clinical neurological assessment revealed bilateral symmetrical weakness, which affects the lower limbs more than the upper limbs, with no evidence of sensory involvement.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 69 REFERENCES
Electrophysiologic and immunopathologic correlates in Guillain–Barré syndrome subtypes
TLDR
Serial electrophysiologic studies are mandatory for identification of GBS subtypes and to elucidate the pathophysiologic mechanisms of muscle weakness among demyelination, axonal degeneration and physiologic conduction block.
The refractory period of transmission is impaired in axonal Guillain–Barré syndrome
TLDR
To compare patterns of conduction block and the safety factor for impulse transmission in AMAN and AIDP, pairs of supramaximal stimuli at intervals of 1–5 ms were delivered to stimulate the median nerve at the wrist.
Pathology of the motor‐sensory axonal Guillain‐Barré syndrome
TLDR
Predictions that some patients with severe motor‐sensory Guillain‐Barré syndrome, as defined clinically, have predominantly axonal lesions of both motor and sensory fibers, even in the early stages of the disease, are confirmed and the pathology supports the possibility that such cases of motor‐Sensory axonal Guillaine‐B Barré syndrome represent the most severe end of a spectrum of immune attack directed toward epitopes on the axon.
Differences in membrane properties of axonal and demyelinating Guillain‐Barré syndromes
TLDR
The results support the view that the predominantly distal targets of immune attack are different for AMAN and AIDP, and Supernormality and threshold electrotonus were normal in both groups of patients, suggesting that, at the wrist, membrane potential was normal and pathology was relatively minor.
Differences in patterns of progression in demyelinating and axonal Guillain–Barré syndromes
TLDR
The patterns and speeds of progression differ in AMAN and AIDP, AMAN having a rapid progression and an early nadir, and AIDs frequently have a significantly long progression after the first examination; therefore, they need to be carefully monitored.
Acute motor axonal neuropathy: An antibody‐mediated attack on axolemma
TLDR
In 7 fatal cases of AMAN, immunocytochemistry demonstrated the presence of IgG and the complement activation product C3d bound to the axolemma of motor fibers, suggesting that AMAN is a novel disorder caused by an antibody‐ and complement‐mediated attack on the axolesmma ofMotor fibers.
Involvement of sensory fibres in axonal subtypes of Guillain–Barré syndrome
TLDR
Sensory fibres are often involved subclinically in AMAN, and reversible conduction failure may develop in sensory as well as motor fibres in both AMAN and AMSAN.
Electrodiagnostic criteria for Guillain–Barrè syndrome: A critical revision and the need for an update
TLDR
More reliable electrodiagnostic criteria should be devised to distinguish axonal and demyelinating subtypes of Guillain-Barré syndrome, taking into consideration the RCF pattern and focussing on temporal dispersion.
IgG Anti‐GM1 antibody is associated with reversible conduction failure and axonal degeneration in guillain‐barré syndrome
TLDR
Rapid resolution of conduction slowing and block, and the absence of remyelinating slow components, suggest that conduction failure may be caused by impaired physiological conduction at the nodes of Ranvier.
Hyperreflexia in Guillain-Barré syndrome: relation with acute motor axonal neuropathy and anti-GM1 antibody
TLDR
Investigating the incidence of hyperreflexia in patients with Guillain-Barré syndrome and its relation with electrodiagnosis of acute motor axonal neuropathy (AMAN), antiganglioside GM1 antibody, and Campylobacter jejuni infection found increased motor neuron excitability further characterises the subgroup of patients with GBS with AMAN and anti-GM1 antibodies.
...
1
2
3
4
5
...